We partner with EU policy-makers and other stakeholders, driven by our purpose: Breakthroughs that change patients’ lives.
Learn more about our team and vision to contribute to more pro-patient and pro-innovation policies in the EU. And don’t hesitate to follow @PfizerEUPolicy on Twitter!
The debate around supply chains for medicines has drastically accelerated with the Covid-19 pandemic. The European Commission’s recent initiative to establish a Structured dialogue on security of medicines supply is an important move. Patients, governments, industry and other supply chain actors all have insights, experiences to contribute.Learn more
The pharmaceutical industry is the most R&D intensive industrial sector in Europe. R&D lies at the core of our innovative industry, bringing with it hope for patients and the prospect of long-term health system sustainability while contributing to Europe’s economic growth.Learn more
The European pharmaceutical industry is a driving force for the European economy delivering a world-class environment for clinical research and pharmaceutical production. It is positioned as the second-largest pharmaceutical market globally, accounting for 22% of all pharmaceutical sales.Learn more
The European Union can play an important role in improving the health of its citizens, and stimulating an innovation-friendly environment.
In this introductory video, our colleagues share their views on the challenges and opportunities ahead for the EU after the 2019 European elections.